Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients globenewswire.com/news-relea…
Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025 globenewswire.com/news-relea…
Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025 globenewswire.com/news-relea…
Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate globenewswire.com/news-relea…
Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Radiopharma Program at EANM 2024 ir.monopartx.com/press-relea…
159
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients globenewswire.com/news-relea…
167
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program globenewswire.com/news-relea…
157
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial
globenewswire.com/news-relea…
133
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
globenewswire.com/news-relea…
94
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers
globenewswire.com/news-relea…
79
Monopar Announces Promising MNPR-202 Data from Ongoing National University of Singapore Collaboration globenewswire.com/news-relea…
Abstracts for the ASH 2022 Conference were released today, please find Monopar's here! ash.confex.com/ash/2022/webp…
1
Monopar Announces Timeline of Upcoming Data Events for Validive, Camsirubicin, and MNPR-202 globenewswire.com/news-relea…
1
Monopar Announces Presentation Selected for 2022 American Society of Hematology (ASH) 64th Annual Meeting
globenewswire.com/news-relea…
Monopar Announces Presentation Selected for 2022 Connective Tissue Oncology Society (CTOS) Annual Meeting
globenewswire.com/news-relea…
Scholars join forces on anti-cancer drug: gatescambridge.org/about/new…
Monopar Advances Dosing of Camsirubicin to Higher Level Than Tested In Any Previous Clinical Trial https://teapawt.net/t.co/xZLc5nXZvr
